ICUI Stock Recent News
ICUI LATEST HEADLINES
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possible violations of federal securities laws. On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products.
NEW YORK CITY, NY / ACCESS Newswire / April 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc.("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possible violations of federal securities laws. On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products.
NEW YORK CITY, NY / ACCESS Newswire / April 30, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI.
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possible violations of federal securities laws. On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products.
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
ICU Medical, Inc. (ICUI) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possible violations of federal securities laws. On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products.
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possible violations of federal securities laws. On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products.
NEW YORK CITY, NY / ACCESS Newswire / April 29, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI.
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possible violations of federal securities laws. On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products.